AZD0780

AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.

Product Specifications

CAS Number

2455427-91-3

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

414.41

Molecular Formula

C20H20F2N6O2

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

AMM09016V 100 µL

Adenylate Kinase 1 (AK1) Mouse Monoclonal Antibody [Clone ID: LBI19G4]

Ask

View Details

AMS0518-01 200 µL

Biotin-conjugated Monoclonal Mouse Anti-Goat IgG Secondary Antibody

Ask

View Details

AMS0518-02 500 µL

Biotin-conjugated Monoclonal Mouse Anti-Goat IgG Secondary Antibody

Ask

View Details

EMk27550 96 Tests

Monkey F12 (F12) ELISA Kit

Ask

View Details

KN512727 1 Kit

P4htm Mouse Gene Knockout Kit (CRISPR)

Ask

View Details